HIV Prevention Injection Could Be Sold for One Thousandth of Current List Price
|
Lenacapavir, a twice-yearly injection that provides nearly
total protection against HIV infection, currently starts at more than
$28,000 per patient ... |
AbbVie's HIV Study: A Potential Game Changer in HIV Treatment
... Antiretroviral Therapy Undergoing Analytical Treatment Interruption. The study aims to assess changes in disease activity, adverse events, and ... View article...